Nicholas Hertz, Montara Therapeutics CEO
March 13, 2025 08:00 AM EDTUpdated 08:11 AM
Financing
Startups

Mon­tara Ther­a­peu­tics adds $20M to seed fundraise for neu­rol­o­gy pipeline

Ayisha Sharma

News Reporter

Mon­tara Ther­a­peu­tics has raised $20 mil­lion in an ex­pand­ed seed fi­nanc­ing to ad­vance a pipeline of pre­clin­i­cal CNS can­di­dates that it says could ad­dress safe­ty …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Up­dat­ed: White House pulls Wel­don's nom­i­na­tion to lead CDC at last minute

Up­dat­ed: En­do and Mallinck­rodt to merge in $6.7B deal

Am­gen re­ports more Up­liz­na da­ta in myas­the­nia gravis ahead of FDA fil­ing

Trump blog: FDA, NIH picks clear Sen­ate pan­el; CDC nom­i­nee pulled at last minute

Ace­lyrin, Pli­ant turn to ‘poi­son pill’ as Kevin Tang’s Con­cen­tra pur­sues both com­pa­nies

sponsored

Obe­si­ty drug de­vel­op­ment—still room to grow

A service from the Financial Times